Evidence map›Paper›PMID 32970665›Full record

ArticlePLoS computational biology2020

Classification of estrogenic compounds by coupling high content analysis and machine learning algorithms.

Rajib Mukherjee, Burcu Beykal, Adam T Szafran, Melis Onel, Fabio Stossi, Maureen G Mancini, Dillon Lloyd, Fred A Wright, Lan Zhou, Michael A Mancini and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Binary Classification of the Endocrine Disrupting Chemicals by Artificial Neural Networks.ESCAPE. European Symposium on Computer Aided Process Engineering · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Rajib MukherjeeTexas A&M Energy Institute, Texas A&M University, College Station, TX, United States of America.ORCID 0000-0002-4938-6210
Burcu BeykalTexas A&M Energy Institute, Texas A&M University, College Station, TX, United States of America.ORCID 0000-0002-6967-6661
Adam T SzafranMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America.ORCID 0000-0002-3033-2378
Melis OnelTexas A&M Energy Institute, Texas A&M University, College Station, TX, United States of America.ORCID 0000-0002-7224-7374
Fabio StossiMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America.ORCID 0000-0001-6029-5478
Maureen G ManciniMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America.
Dillon LloydBioinformatics Research Center, Center for Human Health and the Environment, Department of Statistics, North Carolina State University, Raleigh, NC, United States of America.
Fred A WrightBioinformatics Research Center, Center for Human Health and the Environment, Department of Statistics, North Carolina State University, Raleigh, NC, United States of America.
Lan ZhouDepartment of Statistics, Texas A&M University, College Station, TX, United States of America.
Michael A ManciniMolecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States of America.ORCID 0000-0002-4862-1944
Efstratios N PistikopoulosTexas A&M Energy Institute, Texas A&M University, College Station, TX, United States of America.ORCID 0000-0001-6220-818X
Texas A&M University · USBaylor College of Medicine · USNorth Carolina State University · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Michael M Ittmann · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Single cell, multi-parametric high throughput platform to classify endocrine disruptor potential of mixturesP42ES027704 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu · 2017 to 2026
$21.2M
GRADUATE TRAINING IN BIOINFORMATICST32ES007329 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Fred A. Wright · 2000 to 2026
$6.8M
NCI NIH HHS P30 CA125123NIDDK NIH HHS P30 DK056338NIEHS NIH HHS P42 ES027704NIEHS NIH HHS T32 ES007329
6 · The paper itself

Abstract

Environmental toxicants affect human health in various ways. Of the thousands of chemicals present in the environment, those with adverse effects on the endocrine system are referred to as endocrine-disrupting chemicals (EDCs). Here, we focused on a subclass of EDCs that impacts the estrogen receptor (ER), a pivotal transcriptional regulator in health and disease. Estrogenic activity of compounds can be measured by many in vitro or cell-based high throughput assays that record various endpoints from large pools of cells, and increasingly at the single-cell level. To simultaneously capture multiple mechanistic ER endpoints in individual cells that are affected by EDCs, we previously developed a sensitive high throughput/high content imaging assay that is based upon a stable cell line harboring a visible multicopy ER responsive transcription unit and expressing a green fluorescent protein (GFP) fusion of ER. High content analysis generates voluminous multiplex data comprised of minable features that describe numerous mechanistic endpoints. In this study, we present a machine learning pipeline for rapid, accurate, and sensitive assessment of the endocrine-disrupting potential of benchmark chemicals based on data generated from high content analysis. The multidimensional imaging data was used to train a classification model to ultimately predict the impact of unknown compounds on the ER, either as agonists or antagonists. To this end, both linear logistic regression and nonlinear Random Forest classifiers were benchmarked and evaluated for predicting the estrogenic activity of unknown compounds. Furthermore, through feature selection, data visualization, and model discrimination, the most informative features were identified for the classification of ER agonists/antagonists. The results of this data-driven study showed that highly accurate and generalized classification models with a minimum number of features can be constructed without loss of generality, where these machine learning models serve as a means for rapid mechanistic/phenotypic evaluation of the estrogenic potential of many chemicals.

Indexed as

AlgorithmsMachine LearningCell LineEstrogensHumansReceptors, EstrogenEstrogensReceptors, Estrogen

Identifiers

PMID32970665
PMCPMC7538107
OpenAlexW3087945846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.